647
Views
16
CrossRef citations to date
0
Altmetric
Review

Nanoimaging for prion related diseases

, , , &
Pages 265-274 | Received 01 Jun 2010, Accepted 23 Jul 2010, Published online: 01 Oct 2010
 

Abstract

Misfolding and aggregation of prion proteins is linked to a number of neurodegenerative disorders such as Creutzfeldt-Jacob disease (CJD) and its variants, kuru, Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia. In prion diseases, infectious particles are proteins that propagate by transmitting a misfolded state of a protein, leading to the formation of aggregates and ultimately to neurodegeneration. Prion phenomenon is not restricted to humans. There is a number of prion-related diseases in a variety of mammals, including bovine spongiform encephalopathy (BSE, also known as "mad cow disease") in cattle. All known prion diseases, collectively called transmissible spongiform encephalopathies (TSEs), are untreatable and fatal. Prion proteins were also found in some fungi where they are responsible for heritable traits. Prion proteins in fungi are easily accessible and provide a powerful model for understanding the general principles of prion phenomenon and molecular mechanisms of mammalian prion diseases. Presently, several fundamental questions related to prions remain unanswered. For example, it is not clear how prions cause the disease. Other unknowns include the nature and structure of infectious agent and how prions replicate? Generally, the phenomenon of misfolding of prion protein into infectious conformations that have the ability to propagate their properties via aggregation is of significant interest. Despite the crucial importance of misfolding and aggregation, very little is currently known about the molecular mechanisms of these processes. While there is an apparent critical need to study molecular mechanisms underlying misfolding and aggregation, the detailed characterization of these single molecule processes is hindered by the limitation of conventional methods. Although some issues remain unresolved, much progress has been recently made primarily due to the application of nanoimaging tools. The use of nanoimaging methods shows great promise for understanding the molecular mechanisms of prion phenomenon, possibly leading toward early diagnosis and effective treatment of these devastating diseases. This review article summarizes recent reports which advanced our understanding of the prion phenomenon through the use of nanoimaging methods.

Acknowledgements

The authors thank Luda S. Shlyakhtenko for her help with AFM imaging.

Financial Support

The work was supported by the following grants: DOE (DE-FG02-08ER64579) and NATO (CBN.NR.NRSFP 983204) (all to Y.L.L.).

Figures and Tables

Figure 1 Scheme illustrating that a protein molecule can adopt several conformational states which may result in aggregates of different morphologies. AFM images of CGNNQQNY peptide from Sup35 yeast prion protein aggregated with the formation of fibrils of distinct morphologies at different conditions. Scale bar is 500 nm.

Figure 1 Scheme illustrating that a protein molecule can adopt several conformational states which may result in aggregates of different morphologies. AFM images of CGNNQQNY peptide from Sup35 yeast prion protein aggregated with the formation of fibrils of distinct morphologies at different conditions. Scale bar is 500 nm.

Figure 2 (A) Sketch of a back reflection TERS setup, (B) TERS spectra of a fibril formed by CGNNQQNY peptide from Sup35 yeast prion protein on adjacent points separated by 7 nm.

Figure 2 (A) Sketch of a back reflection TERS setup, (B) TERS spectra of a fibril formed by CGNNQQNY peptide from Sup35 yeast prion protein on adjacent points separated by 7 nm.

Figure 3 Dynamic force spectrum of CGNNQQNY peptide interactions measured at pH 5.6.

Figure 3 Dynamic force spectrum of CGNNQQNY peptide interactions measured at pH 5.6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.